Consistently, silencing of MCL-1 by shRNA in VEN-RE cells reduced OCR, suggesting that in AML cells MCL-1 partially compensates for BCL-2’s role in cellular respiration, yet maintaining lower oxidative capacity. This evidence concerns the gene MCL1 and acute myeloid leukemia.